D-NAP Prophylactic Treatment in the SOD Mutant Mouse Model of Amyotrophic Lateral Sclerosis: Review of Discovery and Treatment of Tauopathy

Protection Against Tauopathy by the Drug Candidates NAP (Davunetide) and D-SAL: Biochemical, Cellular and Behavioral Aspects

(2012) Natalia Shiryaev et al.   CURRENT PHARMACEUTICAL DESIGN

Microtubules (tau) as an Emerging Therapeutic Target: NAP (Davunetide)

(2011) Illana Gozes   CURRENT PHARMACEUTICAL DESIGN

Pathogenesis of the Tauopathies

(2011) Michel Goedert et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Prevention of Learning Deficit in a Down Syndrome Model

(2011) Maddalena Incerti et al.   OBSTETRICS AND GYNECOLOGY

Tau Pathology and Future Therapeutics

(2010) I. Gozes   Current Alzheimer Research

NAP protects against cytochrome c release: Inhibition of the initiation of apoptosis

(2009) Ilona Zemlyak et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

NAP protects against cyanide-related microtubule destruction

(2009) Ilona Zemlyak et al.   JOURNAL OF NEURAL TRANSMISSION

NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model

(2009) Natalia Shiryaev et al.   NEUROBIOLOGY OF DISEASE

A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease

(2008) Y. Matsuoka et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Complete Sequence of a Novel Protein Containing a Femtomolar-Activity-Dependent Neuroprotective Peptide

(2003) Merav Bassan et al.   JOURNAL OF NEUROCHEMISTRY